Abstract
To be able to access an attention deficit hyperactivity disorder (ADHD) service, patients follow a number of pathways. Clinical care pathways for mental health vary according to country, and for the UK have been described since the 1980s. For children with ADHD, these have been revisited more recently but these pathways have yet to be adequately examined for adults. This lack of evidence base has implications for developing models for service delivery for adults with ADHD.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Goldberg D, Huxley P. Mental illness in the community: the pathway to psychiatric care. London: Tavistock; 1980.
Sayal K, Taylor E, Beecham J, Byrne P. Pathways to care in children at risk of attention-deficit hyperactivity disorder. Br J Psychiatry. 2002;181:43–8.
Tettenborn M, Prasad S, Poole L, et al. The provision and nature of ADHD services for children/adolescents in the UK: results from a nationwide survey. Clin Child Psychol Psychiatry. 2008;13:287–304.
Verity R, Coates J. Service innovation: transitional attention-deficit hyperactivity disorder clinic. Psychiatr Bull. 2007;31:99–100.
Singh SP. Transition of care from child to adult mental health services: the great divide. Curr Opin Psychiatry. 2009;22:386–90.
Singh SP, Paul M, Ford T, Kramer T, Weaver T. Transitions of care from child and adolescent mental health services to adult mental health services (track study): a study of protocols in greater London. BMC Health Serv Res. 2008;8:135.
Sayal K, Ford T, Goodman R. Trends in recognition of and service use for attention-deficit hyperactivity disorder in Britain, 1999–2004. Psychiatr Serv. 2010;61:803–10.
Hoagwood K, Kelleher KJ, Feil M, Comer DM. Treatment services for children with ADHD: a national perspective. J Am Acad Child Adolesc Psychiatry. 2000;39:198–206.
Angold A, Erkanli A, Egger HL, Costello EJ. Stimulant treatment for children: a community perspective. J Am Acad Child Adolesc Psychiatry. 2000;39:975–894.
Wasserman RC, Kelleher KJ, Bocian A. Identification of attentional and hyperactivity problems in primary care: a report from pediatric research in office settings and the ambulatory sentinel practice network. Pediatrics. 1999;103:E38.
Zito JM, Safer DJ, dosReis S, Magder LS, Riddle MA. Methylphenidate patterns among Medicaid youths. Psychopharmacol Bull. 1997;33:143–147.
Gardner W, Kelleher KJ, Wasserman R, et al. Primary care treatment of pediatric psychosocial problems: a study from pediatric research in office settings and ambulatory sentinel practice network. Pediatrics. 2000;106:E44.
Nøvik TS, Hervas A, Ralston SJ, et al. For the ADORE study group. Influence of gender on attention-deficit/hyperactivity disorder in Europe-ADORE. Eur Child Adolesc Psychiatry. 2006;15:115–24.
Bussing R, Zima BT, Belin TR. Differential access to care for children with ADHD in special education programs. Psychiatr Serv. 1998;49:1226–9.
Zito JM, Safer DJ, dosReis S, Riddle MA. Racial disparity in psychotropic medications prescribed for youths with Medicaid insurance in Maryland. J Am Acad Child Adolesc Psychiatry. 1998;37:179–184.
Bussing R, Zima BT, Gary FA, et al. Social networks, caregiver strain, and utilization of mental health services among elementary school students at high risk for ADHD. J Am Acad Child Adolesc Psychiatry. 2003;42:842–50.
Taylor E, Dopfner M, Sergeant J, et al. European clinical guidelines for hyperkinetic disorder—first upgrade. Eur Child Adolesc Psychiatry. 2004;13:17–30.
Taylor E, Sergeant J, Dopfner M, et al. Clinical guidelines for hyperkinetic disorder. European society for child and adolescent psychiatry. Eur Child Adolesc Psychiatry. 1998;7:184–200.
National Institute for Health and Clinical Excellence (NICE). NICE guideline CG72: attention deficit hyperactivity disorder: diagnosis and management of ADHD in children, young people and adults. NICE Website. www.nice.org.uk/CG72. Accessed 24 Aug 2012.
Birnbaum HG, Kessler RC, Lowe SW, et al. Costs of attention deficit-hyperactivity disorder (ADHD) in the US: excess costs of persons with ADHD and their family members in 2000. Curr Med Res Opin. 2005;21:195–206.
Hinnenthal JA, Perwien AR, Sterling KL. A comparison of service use and costs among adults with ADHD and adults with other chronic diseases. Psychiatr Serv. 2005;56:1593–9.
Hakkaart-van Roijen L, Zwirs BW, Bouwmans C, et al. Societal costs and quality of life of children suffering from attention deficient hyperactivity disorder (ADHD). Eur Child Adolesc Psychiatry. 2007;16:316–326.
de Ridder A, de Graeve D. Healthcare use, social burden, and costs of children with and without ADHD in Flanders, Belgium. Clin Drug Investig. 2006;26:75–90.
Griffin SC, Weatherly HL, Richardson GA, Drummond MF. Methodological issues in undertaking independent cost-effectiveness analysis for NICE: the case of therapies for ADHD. Eur J Health Econ. 2008;9:137–45.
Kleinman NL, Durkin M, Melkonian A, Markosyan K. Incremental employee health benefit costs, absence days, and turnover among employees with ADHD and among employees with children with ADHD. J Occup Environ Med. 2009;51:1247–55.
Kessler RC, Lane M, Stang PE, van Brunt DL. The prevalence and workplace costs of adult attention deficit hyperactivity disorder in a large manufacturing firm. Psychol Med. 2009;39:137–47.
Halmoy A, Fasmer OB, Gillberg C, Haavik J. Occupational outcome in adult ADHD: impact of symptom profile, comorbid psychiatric problems, and treatment: a cross-sectional study of 414 clinically diagnosed adult ADHD patients. J Atten Disord. 2009;13:175–87.
de Graaf R, Kessler RC, Fayyad J, et al. The prevalence and effects of adult attention-deficit/hyperactivity disorder (ADHD) on the performance of workers: results from the WHO world mental health survey initiative. Occup Environ Med. 2008;65:835–42.
Kessler RC, Adler L, Ames M, et al. The prevalence and effects of adult attention deficit/hyperactivity disorder on work performance in a nationally representative sample of workers. J Occup Environ Med. 2005;47:565–72.
Barkley RA, Murphy KR. Impairment in occupational functioning and adult ADHD: the predictive utility of executive function (EF) ratings versus EF tests. Arch Clin Neuropsychol. 2010;25:157–73.
Kewley GD, Orford E. Attention deficit hyperactivity disorder is under diagnosed and undertreated in Britain: diagnosis needs tightening. BMJ. 1998;316:1594–6.
McCarthy S, Asherson P, Coghill D, et al. Attention-deficit hyperactivity disorder: treatment discontinuation in adolescents and young adults. Br J Psychiatry. 2009;194:273–7.
Wong IC, Asherson P, Bilbow A, et al. Cessation of attention deficit hyperactivity disorder drugs in the young (CADDY)-a pharmacoepidemiological and qualitative study. Health Technol Assess. 2009;13:1–120.
Matheson L, Asherson P, Wong I, et al. P-876—adult ADHD patients’ experiences of impairment, accessing services and treatment management—a qualitative study in England. Eur Psychiatry. 2012;27:1.
Adamou M. Effects and determinants of service provision for adults with ADHD. PhD Thesis. University of Kent; 2011.
Kooij SJ, Bejerot S, Blackwell A, et al. European consensus statement on diagnosis and treatment of adult ADHD: The European network adult ADHD. BMC Psychiatry. 2010;10:67.
Marcer H, Finlay F, Baverstock A. ADHD and transition to adult services-the experience of community paediatricians. Child Care Health Dev. 2008;34:564–6.
Report of the conference on the use of stimulant drugs in the treatment of behaviorally disturbed young school children. Psychopharmacol Bull. 1971;7:23–29.
Author information
Authors and Affiliations
Consortia
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Healthcare
About this chapter
Cite this chapter
UKAAN. (2013). Service Provision for Adults with Attention Deficit Hyperactivity Disorder. In: Handbook for Attention Deficit Hyperactivity Disorder in Adults. Springer Healthcare, Tarporley. https://doi.org/10.1007/978-1-908517-79-1_11
Download citation
DOI: https://doi.org/10.1007/978-1-908517-79-1_11
Published:
Publisher Name: Springer Healthcare, Tarporley
Print ISBN: 978-1-908517-50-0
Online ISBN: 978-1-908517-79-1
eBook Packages: MedicineMedicine (R0)